Patent Troll Bill Clears House; Provisions Problematic For PhRMA Remain
This article was originally published in The Pink Sheet Daily
Amendments make things a little better for drug firms as attention now shifts to the Senate version.
You may also be interested in...
Endo admits to marketing its post-herpetic neuralgia pain drug Lidoderm for unapproved uses in a $192.7 million settlement; National Economic Council Director says there is “a sweet spot for bipartisan compromise” on patent troll bills introduced in the House and Senate.
“One-size-fits-all” patent troll bill will harm innovators, Johnson & Johnson’s chief IP counsel tells Senate hearing.
Michelle Lee, former deputy general counsel of Google, is to lead Patent and Trademark Office until a permanent director is named; new patent reform legislation will be among her areas of focus.